Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 55
15
Diseases
29
Unique genes
0.291
Avg. similarity score
Alpha thalassemia x-linked intellectual disability
Most-connected disease (12 links)
Disease
Searched: Pineocytoma
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Pineocytoma
Alpha thalassemia x-linked intellectual disability
Atr-x syndrome
Lung pecoma
X-linked alpha-thalassemia-intellectual disability syndrome
Alpha-thalassemia intellectual developmental disorder syndrome non-deletion type
Intellectual developmental disorder hypotonic x-linked
Choroid plexus carcinoma
Extra-adrenal sympathetic paraganglioma
Peritoneal well differentiated papillary mesothelioma
Thoracic disease
Penile disease
Placental site trophoblastic tumor
Astroblastoma
Say meyer syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Alpha thalassemia x-linked intellectual disability | 12 | 12 | 1 |
| Atr-x syndrome | 12 | 12 | 1 |
| Lung pecoma | 11 | 11 | 1 |
| X-linked alpha-thalassemia-intellectual disability syndrome | 11 | 11 | 1 |
| Alpha-thalassemia intellectual developmental disorder syndrome non-deletion type | 8 | 8 | 1 |
| Intellectual developmental disorder hypotonic x-linked | 6 | 6 | 2 |
| Choroid plexus carcinoma | 5 | 5 | 7 |
| Extra-adrenal sympathetic paraganglioma | 5 | 5 | 3 |
| Peritoneal well differentiated papillary mesothelioma | 5 | 5 | 3 |
| Pineocytoma | 5 | 5 | 3 |
| Thoracic disease | 5 | 5 | 3 |
| Penile disease | 4 | 4 | 6 |
| Placental site trophoblastic tumor | 3 | 3 | 6 |
| Astroblastoma | 1 | 1 | 7 |
| Say meyer syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATRX | 14 / 15 | Alpha thalassemia x-linked intellectual disability, Alpha-thalassemia intellectual developmental disorder syndrome non-deletion type, Astroblastoma, Atr-x syndrome and 10 more |
| FAT1 | 2 / 15 | Astroblastoma, Extra-adrenal sympathetic paraganglioma |
| HUWE1 | 2 / 15 | Intellectual developmental disorder hypotonic x-linked, Say meyer syndrome |
| RHOA | 2 / 15 | Peritoneal well differentiated papillary mesothelioma, Placental site trophoblastic tumor |
| TP53 | 2 / 15 | Astroblastoma, Choroid plexus carcinoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Endometrial cancer | KEGG | 4 / 59 | 28.1× | 1.14e-5 | 3.24e-4 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 5 / 170 | 12.2× | 4.83e-5 | 1.06e-3 ✓ sig. |
| Colorectal cancer | KEGG | 4 / 87 | 19.0× | 5.31e-5 | 1.14e-3 ✓ sig. |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | Reactome | 4 / 97 | 17.1× | 8.13e-5 | 1.61e-3 ✓ sig. |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | Reactome | 3 / 38 | 32.7× | 1.01e-4 | 1.91e-3 ✓ sig. |
| Ovarian tumor domain proteases | Reactome | 3 / 38 | 32.7× | 1.01e-4 | 1.91e-3 ✓ sig. |
| PI5P Regulates TP53 Acetylation | Reactome | 2 / 9 | 92.0× | 2.01e-4 | 3.29e-3 ✓ sig. |
| Cushing syndrome | KEGG | 4 / 155 | 10.7× | 4.93e-4 | 6.61e-3 ✓ sig. |
| Cell cycle | KEGG | 4 / 158 | 10.5× | 5.30e-4 | 6.98e-3 ✓ sig. |
| Central carbon metabolism in cancer | KEGG | 3 / 71 | 17.5× | 6.48e-4 | 8.17e-3 ✓ sig. |
| Wnt signaling pathway | KEGG | 4 / 174 | 9.5× | 7.62e-4 | 9.20e-3 ✓ sig. |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | Reactome | 2 / 18 | 46.0× | 8.41e-4 | 9.92e-3 ✓ sig. |
| Regulation of TP53 Activity through Methylation | Reactome | 2 / 19 | 43.6× | 9.39e-4 | 1.08e-2 ✓ sig. |
| Formation of the beta-catenin:TCF transactivating complex | Reactome | 3 / 88 | 14.1× | 1.21e-3 | 1.31e-2 ✓ sig. |
| Focal adhesion | KEGG | 4 / 203 | 8.2× | 1.35e-3 | 1.42e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| chromatin remodeling | GO:0006338 | 7 / 320 | 14.1× | 4.57e-7 | 4.51e-5 ✓ sig. |
| multicellular organism growth | GO:0035264 | 5 / 115 | 28.0× | 8.53e-7 | 7.52e-5 ✓ sig. |
| glyoxylate cycle | GO:0006097 | 2 / 2 | 644× | 2.33e-6 | 1.72e-4 ✓ sig. |
| canonical NF-kappaB signal transduction | GO:0007249 | 4 / 62 | 41.6× | 2.45e-6 | 1.79e-4 ✓ sig. |
| response to inositol | GO:1902140 | 2 / 4 | 322× | 1.39e-5 | 7.04e-4 ✓ sig. |
| isocitrate metabolic process | GO:0006102 | 2 / 5 | 258× | 2.32e-5 | 1.03e-3 ✓ sig. |
| transcription initiation-coupled chromatin remodeling | GO:0045815 | 3 / 41 | 47.1× | 3.44e-5 | 1.39e-3 ✓ sig. |
| embryonic organ development | GO:0048568 | 3 / 42 | 46.0× | 3.70e-5 | 1.47e-3 ✓ sig. |
| substrate adhesion-dependent cell spreading | GO:0034446 | 3 / 46 | 42.0× | 4.88e-5 | 1.81e-3 ✓ sig. |
| chromatin organization | GO:0006325 | 6 / 449 | 8.6× | 5.53e-5 | 1.99e-3 ✓ sig. |
| positive regulation of T-helper 17 cell lineage commitment | GO:2000330 | 2 / 8 | 161× | 6.47e-5 | 2.24e-3 ✓ sig. |
| stem cell proliferation | GO:0072089 | 3 / 54 | 35.8× | 7.90e-5 | 2.60e-3 ✓ sig. |
| subtelomeric heterochromatin formation | GO:0031509 | 2 / 11 | 117× | 1.27e-4 | 3.66e-3 ✓ sig. |
| negative regulation of glial cell proliferation | GO:0060253 | 2 / 11 | 117× | 1.27e-4 | 3.66e-3 ✓ sig. |
| NADP+ metabolic process | GO:0006739 | 2 / 14 | 92.1× | 2.09e-4 | 5.24e-3 ✓ sig. |